Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151)

Transplant Proc. 1989 Feb;21(1 Pt 1):293-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure
  • Chronic Disease
  • Disease Models, Animal
  • Fatty Acids, Monounsaturated / therapeutic use*
  • Graft Rejection*
  • Kidney / physiopathology
  • Kidney Transplantation*
  • Pyridines / therapeutic use*
  • Rats
  • Rats, Inbred F344
  • Rats, Inbred Lew
  • Reference Values
  • Thromboxane-A Synthase / antagonists & inhibitors*
  • Transplantation, Homologous
  • Transplantation, Isogeneic

Substances

  • Fatty Acids, Monounsaturated
  • Pyridines
  • Thromboxane-A Synthase
  • isbogrel